A pressure campaign only works on a business whose customers can leave. For each RELX division: what it is, how much it earns, who pays, the alternatives, and whether those alternatives are any cleaner on ICE. Leverage ratings are our judgment.
LexisNexis Legal & Professional
Leverage: HighLegal · Lexis+ · Lexis+ AI · Law360
- 2025 revenue
- £1,806m ($2.4bn)
- Share of RELX
- 19% of revenue · 12% of profit
- Operating margin
- 23.0%
What it sells: Legal research and drafting. Lexis+ is the case law, statutes and Shepard’s citation service that lawyers, judges and law students use every day. Lexis+ AI and the Protégé assistant are the growth engine: RELX says over half of US customers renewing in 2025 adopted Lexis+ AI, and the platform answered five million prompts in the US alone. Also owns Law360, the legal newswire, and Lex Machina.
Who pays: Law firms and corporate legal departments are about 70% of Legal revenue. The rest is government, academic, news and business. RELX says Lexis is in over 210 US law schools. Subscription is 85% of revenue, and RELX describes a typical contract length of three years.
Alternatives
Westlaw (Thomson Reuters)ICE contractor
The other half of the duopoly. Thomson Reuters holds its own ICE contracts: a $22.8m plate-data deal, a $7.4m CLEAR renewal in March 2026, and a proposed $125m CLEAR award. Switching from Lexis to Westlaw moves money from one ICE vendor to the other.
vLex / Fastcase (Clio)No ICE data business found
Full primary law, bought by Clio in 2025. No ICE or DHS data contracts found. Bundled free with many state bar memberships.
Bloomberg LawNo ICE data business found
Full research platform with dockets and news. No ICE data-brokerage contracts found.
CourtListener (Free Law Project)No ICE data business found
Nonprofit, free. Case law, dockets via RECAP, and an API. No commercial data business at all.
HarveyNo ICE data business found
AI legal assistant used by most of the Am Law 100. Private, no data-brokerage business, but it licenses content from the incumbents.
Pressure so far: Students at more than 20 law schools formed the End the Contract coalition in 2021 and protested at LexisNexis headquarters in 2023. Temple Law students demanded their school break ties in April 2026 and Berkeley Law hosted a “Melting ICE” panel in May. No law school is reported to have cancelled. In March 2026 more than 200 journalists at Law360 and MLex, over 80% of their union, signed a letter demanding RELX end the DHS contract. RELX did not respond.
Leverage: The customers are lawyers, the people whose clients ICE targets, and law schools, where the last organizing already happened. Law school library contracts renew on a cycle and are decided by a dean and a library director, not a procurement office. A single top-20 law school switching its student licenses to vLex or Bloomberg Law would be news. Lexis+ AI is also the product RELX is telling investors will carry the company; a reputational hit lands on the growth story.
Elsevier
Leverage: MediumScientific, Technical & Medical
- 2025 revenue
- £2,714m ($3.6bn)
- Share of RELX
- 28% of revenue · 31% of profit
- Operating margin
- 38.1%
What it sells: Academic and medical publishing and data. ScienceDirect (over 20 million researchers a month), Scopus, The Lancet, Cell, ClinicalKey for hospitals, and nursing education tools. Elsevier journals are about 18% of global research output. Journal subscriptions and open-access fees, called Primary Research, are roughly 55% of Elsevier revenue.
Who pays: University libraries, usually through statewide or national consortia, plus hospitals, pharma companies, governments and funders. Subscription is 80% of revenue. Only 43% of Elsevier revenue is North American, so this is RELX’s most global business.
Alternatives
Springer Nature, Wiley, Taylor & FrancisNo ICE data business found
The other large commercial publishers. Same pricing critique, but none run a US law-enforcement data business.
Open access and preprints (arXiv, PLOS, eLife, bioRxiv)No ICE data business found
Free to read. Most of a researcher’s literature is available somewhere open; the missing piece is usually the discovery tool.
OpenAlex vs ScopusNo ICE data business found
OpenAlex is a free, open index of scholarly work. Sorbonne and Twente dropped Clarivate’s Web of Science for it in 2024 and 2025, which shows a research-analytics cancellation is survivable.
UpToDate (Wolters Kluwer) vs ClinicalKeyNo ICE data business found
The dominant clinical reference. No ICE data-brokerage contracts found for Wolters Kluwer.
Pressure so far: The largest customer walkouts in RELX history happened here, and none were about ICE. The University of California cancelled all Elsevier subscriptions in 2019 and stayed out for two years. Germany, Sweden and Norway cancelled national deals. The 2012 Cost of Knowledge boycott drew thousands of researchers. Library groups (SPARC, Portland State library faculty) have flagged RELX as a surveillance vendor, but no consortium has cited ICE as grounds for cancellation.
Leverage: Academic librarians already know how to cancel Elsevier and have done it. They are also the professional community most opposed to vendor surveillance. The argument to make is that the same parent that sells ScienceDirect sells jail-booking data to ICE, and that a Big Deal renewal is a vote of confidence in RELX as a whole. The weakness: researchers need the journals, and a cancellation is a two-year fight.
LexisNexis Risk Solutions: Insurance
Leverage: LowRisk · about 40% of the segment
- 2025 revenue
- ≈£1,400m (≈$1.8bn, derived)
- Share of RELX
- ≈15% of group revenue
- Operating margin
- Risk segment: 37.4%
What it sells: The data insurers use to price and pay claims on you. Claims history (CLUE reports), driving records, telematics from cars, coverage lapses, life-insurance underwriting. RELX calls these “contributory databases”: insurers pool their claims data with LexisNexis and buy back the aggregate. The same contributory model as PSDEX, applied to your car.
Who pays: Personal auto, home, commercial and life insurance carriers, almost all in the US. LexisNexis says it works with 95 of the top 100 US carriers and touched 86% of new US auto policies in 2023.
Alternatives
VeriskData broker · no ICE contract found
The other insurance data giant. Named by RELX as its main competitor. Not a law-enforcement data broker, though it sells property and claims data broadly.
Carrier-built dataNo ICE data business found
Large insurers can and do build their own telematics and claims models.
Pressure so far: No ICE-related pressure. The public fights here are consumer class actions over driving-data sharing (the 2024 GM and OnStar cases named LexisNexis and Verisk) and Fair Credit Reporting Act suits.
Leverage: Low as a direct target. Insurers do not answer to students or librarians and the switching cost is high. Useful as a talking point: LexisNexis’s consumer-facing exposure (your CLUE report, your driving score) is the reason regulators and state attorneys general already have jurisdiction over it.
LexisNexis Risk Solutions: Business Services
Leverage: LowRisk · over 40% of the segment
- 2025 revenue
- ≈£1,450m (≈$1.9bn, derived)
- Share of RELX
- ≈15% of group revenue
- Operating margin
- Risk segment: 37.4%
What it sells: Fraud, identity verification and financial-crime compliance for banks, fintechs and online retailers. ThreatMetrix device intelligence, Emailage, Bridger Insight sanctions screening, and the LexID identity graph. LexID is the same identity-resolution engine ICE names in its 2026 sole-source justification.
Who pays: Banks, payment companies, crypto exchanges, gambling operators and e-commerce, worldwide. This is RELX’s fastest-growing and most international Risk business.
Alternatives
Experian, Equifax, TransUnionData broker · no ICE contract found
The credit bureaus, named by RELX as its main competitors here and in Government. All three are data brokers in their own right.
Socure, Onfido, Jumio, PersonaNo ICE data business found
Identity-verification specialists without a law-enforcement data line.
Pressure so far: None related to ICE.
Leverage: Low as a public target. Relevant because it shows what RELX would protect first if forced to choose: a global fraud business built on the same LexID graph that ICE is buying. Bank compliance officers do not want to see “LexisNexis” next to “deportation” in the news.
RX (Reed Exhibitions) and ReedPop
Leverage: MediumExhibitions · trade shows and fan conventions
- 2025 revenue
- £1,186m ($1.6bn)
- Share of RELX
- 12% of revenue · 12% of profit
- Operating margin
- 34.6%
What it sells: 274 face-to-face events in 25 countries, six million participants in 2025. Trade shows like MIPIM (real estate), JCK (jewelry), World Travel Market and Arabian Travel Market, plus ReedPop’s fan conventions: New York Comic Con, Emerald City Comic Con, C2E2, PAX, and BookCon.
Who pays: Exhibitors and attendees. Only 20% of RX revenue is North American. The consumer-facing ReedPop shows are the part of RELX that ordinary people actually walk into.
Alternatives
Independent conventionsNo ICE data business found
Fan Expo (Informa), San Diego Comic-Con (nonprofit), Dragon Con, and regional shows.
Pressure so far: A cosplayer petition, “ICE Out of Our Conventions,” targeted Emerald City Comic Con in early 2026. In February 2026 dozens of authors, including R.F. Kuang and Casey McQuiston, signed an open letter to RELX’s chief executive, finance chief and chair over ICE; Carmen Maria Machado and Sabaa Tahir withdrew from BookCon. ReedPop said it operates “on an arm’s length basis” from other RELX businesses and does not sell customer data to DHS.
Leverage: Medium, and the only place the public can reach RELX directly. A convention runs on guests. Authors, artists and voice actors declining to appear is visible, cheap, and already happening. NYCC is in October in a city with an active immigrant-rights movement. The ask should be aimed at RELX, not at the fans.